Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.

Gootz TD, Zaniewski R, Haskell S, Schmieder B, Tankovic J, Girard D, Courvalin P, Polzer RJ.

Antimicrob Agents Chemother. 1996 Dec;40(12):2691-7.

2.

Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase.

Clancy J, Schmieder BJ, Petitpas JW, Manousos M, Williams JA, Faiella JA, Girard AE, McGuirk PR.

J Antibiot (Tokyo). 1995 Nov;48(11):1273-9.

3.

In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.

Gootz TD, Brighty KE, Anderson MR, Schmieder BJ, Haskell SL, Sutcliffe JA, Castaldi MJ, McGuirk PR.

Diagn Microbiol Infect Dis. 1994 Aug;19(4):235-43.

PMID:
7851087
4.

Fractionation of particulate material from maize coleoptile homogenates with polyethylene glycol.

Michalke W, Schmieder B.

Planta. 1979 Jan;145(2):129-35. doi: 10.1007/BF00388708.

PMID:
24317667

Supplemental Content

Loading ...
Support Center